Clinical trials for

Optic Neuropathy

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingInterventional

Vienna, AustriaCheck eligibility →

RecruitingSafety & dosing

Palo Alto, California, United StatesCheck eligibility →

RecruitingObservational

Montreal, Quebec, CanadaCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Beijing, ChinaCheck eligibility →

RecruitingInterventional

Munich, Bavaria, GermanyCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Washington D.C., District of Columbia, United States +4 moreCheck eligibility →

RecruitingEarly testing / Safety & dosing

Xi'an, Shaanxi, ChinaCheck eligibility →

RecruitingPost-approval study

Tianjin, ChinaCheck eligibility →

RecruitingObservational

Reims, FranceCheck eligibility →

RecruitingInterventional

Palo Alto, California, United StatesCheck eligibility →

RecruitingObservational

Alexandria, Egypt +1 moreCheck eligibility →

RecruitingInterventional

Helsinki, FinlandCheck eligibility →

RecruitingLarge-scale testing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingInterventional

Nanjing, Jiangsu, ChinaCheck eligibility →

RecruitingObservational

London, Ontario, Canada +4 moreCheck eligibility →

RecruitingEarly testing

Houston, Texas, United StatesCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingLarge-scale testing

San Francisco, California, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Bordeaux, France +4 moreCheck eligibility →

RecruitingObservational

Marseille, FranceCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingInterventional

Vienna, AustriaCheck eligibility →

RecruitingSafety & dosing

Palo Alto, California, United StatesCheck eligibility →

RecruitingObservational

Montreal, Quebec, CanadaCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Beijing, ChinaCheck eligibility →

RecruitingInterventional

Munich, Bavaria, GermanyCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Washington D.C., District of Columbia, United States +4 moreCheck eligibility →

RecruitingEarly testing / Safety & dosing

Xi'an, Shaanxi, ChinaCheck eligibility →

RecruitingPost-approval study

Tianjin, ChinaCheck eligibility →

RecruitingObservational

Reims, FranceCheck eligibility →

RecruitingInterventional

Palo Alto, California, United StatesCheck eligibility →

RecruitingObservational

Alexandria, Egypt +1 moreCheck eligibility →

RecruitingInterventional

Helsinki, FinlandCheck eligibility →

RecruitingLarge-scale testing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingInterventional

Nanjing, Jiangsu, ChinaCheck eligibility →

RecruitingObservational

London, Ontario, Canada +4 moreCheck eligibility →

RecruitingEarly testing

Houston, Texas, United StatesCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingLarge-scale testing

San Francisco, California, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Bordeaux, France +4 moreCheck eligibility →

RecruitingObservational

Marseille, FranceCheck eligibility →

104 trials · Recruiting

104

Trials actively recruiting patients for Optic Neuropathy

Trial status

Phase

Location